ImmunityBio (26CA.F) Q2 2024 Earnings

May 9Confirmed
Q4 2023
Q2 2024
-0.33
-0.28
-0.22
-0.17

Details

Expected EPS
-0.18080400000000002
Actual EPS
-0.166896
Surprise EPS
0.01
Surprise Percent
+7.69%

Description

⁨ImmunityBio⁩ (⁦26CA.F⁩) has reported earnings of ⁦-0.166896⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts